MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2012 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
69.3 M |
Marktkapitalisierung |
$ 650 M |
EBITDA (LTM) |
$ -193 M |
P/E (LTM) |
-5.36 |
P/S (LTM) |
6.481997 |
EPS (LTM) |
-1.75 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB |  Russia |
 |
Voyager Therapeutics
VYGR
|
$ 1.75 | -6.68 % | $ 103 M | Nasdaq Global Select Market | USA |
 |
Precision BioSciences
DTIL
|
$ 10.24 | 26.11 % | $ 131 M | Nasdaq Global Select Market | USA |
 |
MediWound Ltd.
MDWD
|
$ 13.33 | -6.13 % | $ 363 M | Nasdaq Global Select Market |  Israel |
 |
Nektar Therapeutics
NKTR
|
$ 36.18 | -5.98 % | $ 610 M | Nasdaq Global Select Market,SPB | USA |
 |
NanoViricides
NNVC
|
$ 1.28 | -7.25 % | $ 25.8 M | NYSE American | USA |
 |
Zoetis
ZTS
|
$ 81.84 | -8.23 % | $ 36.3 B | NYSE,SPB | USA |
 |
Intellia Therapeutics
NTLA
|
$ 11.12 | -9.67 % | $ 1.21 B | Nasdaq Global Market,SPB | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Novartis AG
NVS
|
$ 161.95 | -1.85 % | $ 314 B | NYSE |  Schweiz |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Ocugen
OCGN
|
$ 0.81 | -7.94 % | $ 253 M | Nasdaq Capital Market | USA |
 |
Omeros Corporation
OMER
|
$ 17.05 | -6.08 % | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.45 | 5.32 % | $ 43.1 M | Nasdaq Global Select Market |  Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 8.47 | -9.37 % | $ 744 M | Nasdaq Global Select Market | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 3.91 | -5.45 % | $ 162 M | Nasdaq Global Select Market | Israel |
 |
Puma Biotechnology
PBYI
|
$ 9.88 | -7.58 % | $ 494 M | Nasdaq Global Select Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.17 | -10.0 % | $ 54.3 M | Nasdaq Capital Market | USA |
 |
Pfizer
PFE
|
$ 30.03 | -2.47 % | $ 171 B | NYSE,SPB | USA |
 |
Pharming Group N.V.
PHAR
|
$ 12.53 | 0.56 % | $ 8.63 B | Nasdaq Global Select Market |  Niderland |
 |
Phathom Pharmaceuticals
PHAT
|
$ 5.07 | -10.83 % | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.81 | -4.85 % | $ 49.7 M | Nasdaq Global Select Market | USA |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.51 | -6.69 % | $ 197 M | NYSE American | Israel |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.28 | -3.4 % | $ 67.3 M | Nasdaq Global Select Market | USA |
 |
PTC Therapeutics
PTCT
|
$ 65.61 | -4.87 % | $ 5.22 B | Nasdaq Global Select Market,SPB | USA |
 |
BioVie
BIVI
|
$ 1.21 | -9.7 % | $ 1.79 M | Nasdaq Capital Market | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 135.02 | -6.05 % | $ 8.58 B | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.46 | -4.28 % | $ 5.33 B | Nasdaq Global Select Market | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | Israel |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.44 | -6.7 % | $ 271 M | Nasdaq Global Select Market | USA |
 |
Arcus Biosciences
RCUS
|
$ 17.96 | -6.92 % | $ 1.93 B | NYSE,SPB | USA |
 |
Cabaletta Bio
CABA
|
$ 1.26 | -10.92 % | $ 127 M | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Relay Therapeutics
RLAY
|
$ 17.0 | -5.74 % | $ 2.92 B | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Avidity Biosciences
RNA
|
$ 8.34 | -3.92 % | $ 1.15 B | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
Royalty Pharma plc
RPRX
|
$ 67.55 | -0.02 % | $ 29 B | Nasdaq Global Select Market | USA |
 |
Revolution Medicines
RVMD
|
$ 177.88 | -10.93 % | $ 33.8 B | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 105.13 | -5.01 % | $ 6.83 B | Nasdaq Global Market,SPB | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.42 | 0.62 % | $ 5.18 B | Nasdaq Global Market | Israel |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |